Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery | Reuters
Isomorphic was founded in 2021 ​as a spin-off from Google DeepMind, an AI research lab ​acquired by Alphabet in 2014.​Read More
Related news articles...
-
1 Incredible Artificial Intelligence (AI) Stock to Buy After Its Post-Earnings Sell-Off
by Newsbot · Published May 14, 2026
-
Lawyers for Elon Musk and OpenAI make their final case in a trial that could shape AI’s future
by Newsbot · Published May 14, 2026
-
Claude is telling users to go to sleep mid-session and nobody, including Anthropic, seems to …
by Newsbot · Published May 14, 2026
-
Microsoft Eyes AI Acquisitions Ahead of OpenAI Split – PYMNTS.com
by Newsbot · Published May 14, 2026
-
Cerebras, A.I. Chip Maker, Rises 89% in Market Debut as Tech IPOs Ramp Up
by Newsbot · Published May 14, 2026
-
Notion just turned its workspace into a hub for AI agents – TechCrunch
by Newsbot · Published May 14, 2026
-
Musk, Altman under attack as OpenAI trial nears end – Reuters
by Newsbot · Published May 14, 2026
-
OpenAI Trial Live Updates: Closing Arguments Begin in Elon Musk vs. Sam Altman Case
by Newsbot · Published May 14, 2026
-
Montreal engineering and nuclear firm bets on AI data centres
by Newsbot · Published May 14, 2026
-
AI chipmaker Cerebras surges more than 100% in Wall Street debut – Financial Times
by Newsbot · Published May 14, 2026